Haoxi Health Technology Secures Major Funding
Haoxi Health Technology Limited, commonly known as HAO, has captured attention recently by successfully completing a follow-on public offering that raised an impressive $12 million. This substantial investment emphasizes the company's strong position in the online marketing solutions sector, particularly in services designed for the healthcare industry.
Details of the Offering
The latest offering consisted of 4,000,000 units, each priced at $3.00, reflecting the company’s dedication to solidifying its financial foundation. Each unit includes a Class A Ordinary Share or a pre-funded warrant for purchasing one Class A Ordinary Share, along with two types of warrants that enable investors to buy additional shares at a set price.
Overall, Haoxi garnered gross proceeds amounting to $12 million from this offering, which is essential for achieving its strategic objectives. The funds will primarily be directed towards promoting business growth and making technological advancements in the healthcare marketing sector.
Role of Underwriters
EF Hutton LLC served as the sole bookrunner for this offering and retains an option to purchase extra units to manage any over-allotments, indicating strong confidence in Haoxi's potential within the market. Legal support was provided by Hunter Taubman Fischer & Li LLC for Haoxi and by Pryor Cashman LLP for EF Hutton.
CEO’s Perspective
Mr. Zhen Fan, the Chairman and CEO of Haoxi, expressed a positive outlook regarding the funding, stating, “We are pleased to close this offering and appreciate the continued support and market recognition as we execute our business plan.” His comments reflect the enthusiasm within the company as it seeks to expand its reach.
Company Overview
Founded in Beijing, Haoxi Health Technology Limited specializes in delivering online marketing solutions tailored specifically for the healthcare industry. The company's growth has been fueled by the increasing popularity of news feed advertisements and the fast-paced changes occurring in China's healthcare landscape.
What sets Haoxi apart is its comprehensive online marketing strategy, which emphasizes short video marketing across popular platforms like Toutiao, Douyin, WeChat, and Sina Weibo. This approach enables their clients to acquire and retain customers more efficiently, all while keeping costs low. It's a clear demonstration of Haoxi's grasp of the current digital environment.
Looking Ahead
With the proceeds from this recent offering, Haoxi is well-prepared to further invest in innovative marketing solutions and technology. Their goal is to enhance their capabilities even more, aiming to meet and exceed the expectations of their healthcare clients.
This significant development reflects a strong commitment to the future, signaling that Haoxi Health Technology Limited is determined to play a key role in shaping the digital marketing landscape within the healthcare sector.
Frequently Asked Questions
What is the purpose of Haoxi Health Technology's recent public offering?
The public offering aims to raise capital to support the company's expansion efforts and technological investments in the healthcare industry.
How many units were offered in this public offering?
A total of 4,000,000 units were offered, each priced at $3.00.
Who acted as the underwriter for the offering?
EF Hutton LLC acted as the sole bookrunner for this offering.
What services does Haoxi Health Technology provide?
Haoxi focuses on offering online marketing solutions, specifically aimed at advertisers in the healthcare industry, with a strong emphasis on short video marketing strategies.
What is the significance of this offering for Haoxi Health Technology?
This offering is a crucial capital boost that will allow Haoxi to invest further in innovative marketing solutions and expand its market presence.
